Medline Convenience Kits Recall Over Biopsy Valve Issue
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Medline Industries is recalling 14,379 convenience kits containing Olympus biopsy valves due to potential rubber fragment detachment, which could lead to health risks.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 15, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, cpsc, Devices.
What Happened
Medline Industries, LP is recalling certain convenience kits because they contain recalled Olympus biopsy valves. The recall is due to an increase in complaints about rubber fragment detachment, which may result in a foreign body in the patient's tracheobronchial tree, potentially requiring intervention, along with risks of inflammatory response, hypoxia, and prolonged procedures.
Which Products Are Affected
The affected products are:
- BRONCH PACK, DYKE2096
- NON MB BRONCHOPSCOPY CCH LH PK, DYNJT6182
- PULMONARY BRONCH PACK, DYNDA2861A A total of 14,379 kits are affected. The kits include the following code information: 1. UDI-DI 10198459629334 (EA) 40198459629335 (CS) LOTS 26AMG895; 2. UDI-DI 10198459545283 (EA) 40198459545284 (CS) LOTS 25LBJ366 26ABR365; 3. UDI-DI 10195327471859 (EA) 40195327471850 (CS) LOTS 24EBA317 24EBV431 24IBD694 24JBQ783. Distribution occurred nationwide in the United States, specifically in the states of CA, FL, IL, IN, KY, MA, MD, MT, NY, OH, PA, TN, and TX. The recall number is Z-1706-2026.
What You Should Do
Consumers and healthcare providers should contact Medline Industries, LP at their address: 3 Lakes Dr, Northfield, IL 60093-2753, for further instructions regarding this voluntary recall initiated by the firm.
Why This Matters
This recall addresses potential health risks from defective biopsy valves in medical kits, which could lead to serious complications for patients undergoing procedures, highlighting the importance of device safety in healthcare.
Source
FDA recall notice, event ID 98530, recall number Z-1706-2026. Attribution: FDA (U.S. Food and Drug Administration).
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,660 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to April 15, 2026.
Frequently Asked Questions
Common questions about this FDA recall.